2 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Phase III Randomized International Open Label Clinical Trial of Treatment Intensification With Docetaxel Plus Apalutamide in Patients With Metastatic Hormone-sensitive Prostate Cancer Who Did Not Achieve a Deep PSA Response After Initial Treatment With Apalutamide: REINFORCE Trial.Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorderRecruitingPhase 32026-06-17NCT07333066
APrevent-VOIS-Implant-002 - a Two-Part, Open-Label, Non-Randomized Multicenter StudyNeurologic Manifestations, Paralysis, Unilateral, Vocal Cord, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Vocal Cord Paralysis, cranial nerve neuropathy, laryngeal disorder, nervous system disorder, otorhinolaryngologic disease, palsy, respiratory system disorder, vagus nerve disorderRecruitingNot applicable2025-02-06NCT05119842